ACTIVELLA®—Prescription hormone therapy with an estrogen just like your own. Now you can replace what your body is missing with what you want in a hormone therapy.
ACTIVELLA® 0.5mg/0.1 mg bleeding profile
In a clinical trial, ACTIVELLA® 0.5 mg/0.1 mg demonstrated a similar bleeding profile when compared with placebo.1,8
88% of women treated with ACTIVELLA® 0.5 mg/0.1 mg were amenorrheic after 6 months.1 Only 1% of women treated with ACTIVELLA® 0.5 mg/0.1 mg discontinued because of bleeding.9
- 1. ACTIVELLA® [package insert]. Princeton, NJ: Novo Nordisk Inc; 2007.
- 8. Panay N, Ylikorkala O, Archer DF, Gut R, Lang E. Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief. Climacteric. 2007;10:120-131.
- 9. Data on file. CTR. Novo Nordisk Inc, Princeton, NJ. Trial ID: ALD-1537.
